肾移植前后肾脏病症状负担变化研究
该研究纳入1298例肾移植候选者和521例受者,发现候选期16%报告高症状负担、21%报告极高负担,极高负担者等待期死亡风险增加(校正sHR 1.67,95%CI 1.06–2.62);移植后3个月内症状评分从82.3分升至90.6分,9/11症状早期改善,瘙痒和疲乏改善最大。
要点
- 候选期极高症状负担与等待期死亡风险增加相关(校正sHR 1.67,95%CI 1.06–2.62)。
- 移植时34%症状负担加重、42%不变,但移植后3个月内总体症状评分改善约10%。
- 移植后0–3个月症状评分每月增加2.75分,3–12个月趋于平台。
核心结论
- 候选期极高症状负担与等待期死亡风险增加相关,存活并接受移植者症状在术后早期改善。
研究设计与样本
- 两中心前瞻性研究,纳入1298例肾移植候选者和521例受者(2014年5月至2020年3月)。
- 症状评分(0–100)基于肾脏病生活质量简表调查,评分越低负担越重。
- 负担分级:极高0.0–71.0,高71.1–81.0,中81.1–91.0,低91.1–100.0。
- 采用竞争风险回归估计等待期死亡风险,混合效应模型分析移植后症状轨迹。
主要发现
- 评估时32%候选者报告疲乏中度至极度困扰,27%报告皮肤干燥,26%报告肌肉酸痛,25%报告瘙痒。
- 评估时16%报告高症状负担,21%报告极高症状负担。
- 极高症状负担候选者等待期死亡风险更高(校正sHR 1.67,95%CI 1.06–2.62)。
- 至移植时34%症状负担增加,42%保持不变。
- 移植时总体症状评分82.3分,术后3个月90.6分(改善10%);0–3个月每月增加2.75分(95%CI 2.38–3.13),3–12个月趋于平台(每月-0.06分,95%CI -0.30–0.18)。
临床怎么用
- 肾移植候选期应评估症状负担,极高负担者需关注等待期死亡风险。
- 移植后早期(3个月内)症状可明显改善,应加强术后症状管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with kidney failure report a high symptom burden, which likely increases while on dialysis due to physical and mental stressors and decreases after kidney transplantation due to restoration of kidney function. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We leveraged a two-center prospective study of 1298 kidney transplant candidates and 521 recipients (May 2014 to March 2020). Symptom scores (0-100) at evaluation and admission for transplantation were calculated using the Kidney Disease Quality of Life Short-Form Survey, where lower scores represent greater burden, and burden was categorized as very high: 0.0-71.0; high: 71.1-81.0; medium: 81.1-91.0; and low: 91.1-100.0. We estimated adjusted waitlist mortality risk (competing risks regression), change in symptoms between evaluation and transplantation (n=190), and post-transplantation symptom score trajectories (mixed effects models). RESULTS: At evaluation, candidates reported being moderately to extremely bothered by fatigue (32%), xeroderma (27%), muscle soreness (26%), and pruritus (25%); 16% reported high and 21% reported very high symptom burden. Candidates with very high symptom burden were at greater waitlist mortality risk (adjusted subdistribution hazard ratio, 1.67; 95% confidence interval, 1.06 to 2.62). By transplantation, 34% experienced an increased symptom burden, whereas 42% remained unchanged. The estimated overall symptom score was 82.3 points at transplantation and 90.6 points at 3 months (10% improvement); the score increased 2.75 points per month (95% confidence interval, 2.38 to 3.13) from 0 to 3 months, and plateaued (-0.06 points per month; 95% confidence interval, -0.30 to 0.18) from 3 to 12 months post-transplantation. There were early (first 3 months) improvements in nine of 11 symptoms; pruritus (23% improvement) and fatigue (21% improvement) had the greatest improvements. CONCLUSIONS: Among candidates, very high symptom burden was associated with waitlist mortality, but for those surviving and undergoing kidney transplantation, symptoms improved.
引用
- Taylor K, Chu NM, Chen X, et al. Kidney Disease Symptoms before and after Kidney Transplantation. Clin J Am Soc Nephrol. 2021. PMID: 34597266. doi:10.2215/CJN.19031220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。